Heparanase has been strongly correlated with metastatic potential in human cancer probably by disrupting the structure of basement membranes and by releasing HS saccharide growth factor complexes from the pericellular matrix enabling their unrestricted access to cell-surface receptors (Elkin et al, 2001). Here, CD177 is linked to cancer.